|
HY-P71397-5ug
|
MedChemexpress LLC
|
UBE2A, Human (GST-His)
|
|
|
|
|
HY-P71397-50ug
|
MedChemexpress LLC
|
UBE2A, Human (GST-His)
|
|
|
|
|
HY-147087-10mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
|
HY-147087-100mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
|
HY-147087-25mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
|
HY-147087-5mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
|
HY-147087-50mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
|
HY-147087-1mL
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P74424-50ug
|
MedChemexpress LLC
|
AGO1, Human (sf9, His)
|
|
|
|
|
HY-P72835-100ug
|
MedChemexpress LLC
|
AGO2/Argonaute-2, Human (sf9, His)
|
|
|
|
|
HY-P74423-10ug
|
MedChemexpress LLC
|
AGO2/Argonaute-2, Mouse (sf9, His)
|
|
|
|
|
HY-P74423-20ug
|
MedChemexpress LLC
|
AGO2/Argonaute-2, Mouse (sf9, His)
|
|
|
|
|
HY-P74423-50ug
|
MedChemexpress LLC
|
AGO2/Argonaute-2, Mouse (sf9, His)
|
|
|
|
|
HY-P70014-10ug
|
MedChemexpress LLC
|
CDK2, Human (His)
|
|
|
|
|
HY-P70014-50ug
|
MedChemexpress LLC
|
CDK2, Human (His)
|
|
|
|
|
HY-P70014A-50ug
|
MedChemexpress LLC
|
CDK2, Human (N-His)
|
|
|
|
|
HY-P70014A-500ug
|
MedChemexpress LLC
|
CDK2, Human (N-His)
|
|
|
|
|
HY-112758-10mg
|
MedChemexpress LLC
|
DLin-KC2-DMA [CAS 1190197-97-7]
|
|
|
|
|
HY-112758-100mg
|
MedChemexpress LLC
|
DLin-KC2-DMA [CAS 1190197-97-7]
|
|
|
|
|
HY-112758-5mg
|
MedChemexpress LLC
|
DLin-KC2-DMA [CAS 1190197-97-7]
|
|
|
|
|
HY-112758-50mg
|
MedChemexpress LLC
|
DLin-KC2-DMA [CAS 1190197-97-7]
|
|
|
|
|
HY-135127-1mg
|
MedChemexpress LLC
|
Dot1L-IN-4 [CAS 2565705-02-2]
|
|
Cancer-programmed cell death
|
|
|
HY-135127-10mg
|
MedChemexpress LLC
|
Dot1L-IN-4 [CAS 2565705-02-2]
|
|
Cancer-programmed cell death
|
|
|
HY-135127-100mg
|
MedChemexpress LLC
|
Dot1L-IN-4 [CAS 2565705-02-2]
|
|
Cancer-programmed cell death
|
|
|
HY-135127-25mg
|
MedChemexpress LLC
|
Dot1L-IN-4 [CAS 2565705-02-2]
|
|
Cancer-programmed cell death
|
|
